FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073375483> ?p ?o ?g. }

• W2073375483 endingPage "111" @default.
• W2073375483 startingPage "106" @default.
• W2073375483 abstract "Background & Aims: NOD2/CARD15 was recently identified as the first gene underlying Crohn's disease (CD) susceptibility. Monoclonal antibodies to tumor necrosis factor (TNF)-α (infliximab) are a potent treatment for CD, with about 70% of patients responding. It is not clear which factors influence treatment outcome. We assessed whether variants in NOD2/CARD15 are predictive for differences in clinical response. Methods: Two hundred forty-five CD patients (86 fistulizing, 159 luminal) receiving infliximab in an expanded access program were genotyped for the 3 main associated variants of NOD2/CARD15, without knowledge of the treatment response. Short-term clinical response was assessed at 4 weeks (refractory) or 10 weeks (fistulizing) after first infliximab infusion, and the mean duration of response was calculated. In a subgroup of patients, production of TNF in response to lipopolysaccharide (LPS) in mucosal biopsy tissue was also determined by means of immunoassay, and results were related to the different NOD2/CARD15 genotypes. Results: In total, 32.6% of patients carried mutations in NOD2/CARD15 (18.8% R702W, 8.6% G908R, and 10.2% 1007fs) compared with 15% in controls (P < 0.001). Despite observed differences in TNF production in mucosal biopsy tissue, there was no relationship between the overall presence of a mutation in NOD2/CARD15 or of any of the mutations separately and short-term infliximab response or response duration. Furthermore, multivariate analysis could not identify clinical characteristics that, in combination with NOD2/CARD15 mutations, were associated with response to infliximab. Conclusions: In this cohort of CD patients, the frequency of NOD2/CARD15 mutations was significantly greater than that of healthy controls. However, NOD2/CARD15 was not predictive of treatment outcome with infliximab in CD.GASTROENTEROLOGY 2002;123:106-111" @default.
• W2073375483 created "2016-06-24" @default.
• W2073375483 creator A5001314589 @default.
• W2073375483 creator A5011580404 @default.
• W2073375483 creator A5015470174 @default.
• W2073375483 creator A5019474609 @default.
• W2073375483 creator A5022849571 @default.
• W2073375483 creator A5026868068 @default.
• W2073375483 creator A5041656258 @default.
• W2073375483 creator A5042564659 @default.
• W2073375483 creator A5052113690 @default.
• W2073375483 creator A5066330523 @default.
• W2073375483 creator A5071357575 @default.
• W2073375483 creator A5075153118 @default.
• W2073375483 creator A5077220554 @default.
• W2073375483 creator A5083690903 @default.
• W2073375483 creator A5085993019 @default.
• W2073375483 date "2002-07-01" @default.
• W2073375483 modified "2023-10-17" @default.
• W2073375483 title "NOD2/CARD15 does not influence response to infliximab in Crohn's disease" @default.
• W2073375483 cites W1642457845 @default.
• W2073375483 cites W1670573097 @default.
• W2073375483 cites W1975348681 @default.
• W2073375483 cites W2021706207 @default.
• W2073375483 cites W2024162533 @default.
• W2073375483 cites W2083289600 @default.
• W2073375483 cites W2085074544 @default.
• W2073375483 cites W2086607027 @default.
• W2073375483 cites W2122443382 @default.
• W2073375483 cites W2149085554 @default.
• W2073375483 cites W2152532561 @default.
• W2073375483 cites W2171655564 @default.
• W2073375483 cites W2321453230 @default.
• W2073375483 cites W2326330820 @default.
• W2073375483 doi "https://doi.org/10.1053/gast.2002.34172" @default.
• W2073375483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12105838" @default.
• W2073375483 hasPublicationYear "2002" @default.
• W2073375483 type Work @default.
• W2073375483 sameAs 2073375483 @default.
• W2073375483 citedByCount "201" @default.
• W2073375483 countsByYear W20733754832012 @default.
• W2073375483 countsByYear W20733754832013 @default.
• W2073375483 countsByYear W20733754832014 @default.
• W2073375483 countsByYear W20733754832015 @default.
• W2073375483 countsByYear W20733754832016 @default.
• W2073375483 countsByYear W20733754832017 @default.
• W2073375483 countsByYear W20733754832018 @default.
• W2073375483 countsByYear W20733754832019 @default.
• W2073375483 countsByYear W20733754832020 @default.
• W2073375483 countsByYear W20733754832021 @default.
• W2073375483 countsByYear W20733754832022 @default.
• W2073375483 countsByYear W20733754832023 @default.
• W2073375483 crossrefType "journal-article" @default.
• W2073375483 hasAuthorship W2073375483A5001314589 @default.
• W2073375483 hasAuthorship W2073375483A5011580404 @default.
• W2073375483 hasAuthorship W2073375483A5015470174 @default.
• W2073375483 hasAuthorship W2073375483A5019474609 @default.
• W2073375483 hasAuthorship W2073375483A5022849571 @default.
• W2073375483 hasAuthorship W2073375483A5026868068 @default.
• W2073375483 hasAuthorship W2073375483A5041656258 @default.
• W2073375483 hasAuthorship W2073375483A5042564659 @default.
• W2073375483 hasAuthorship W2073375483A5052113690 @default.
• W2073375483 hasAuthorship W2073375483A5066330523 @default.
• W2073375483 hasAuthorship W2073375483A5071357575 @default.
• W2073375483 hasAuthorship W2073375483A5075153118 @default.
• W2073375483 hasAuthorship W2073375483A5077220554 @default.
• W2073375483 hasAuthorship W2073375483A5083690903 @default.
• W2073375483 hasAuthorship W2073375483A5085993019 @default.
• W2073375483 hasBestOaLocation W20733754831 @default.
• W2073375483 hasConcept C126322002 @default.
• W2073375483 hasConcept C17991360 @default.
• W2073375483 hasConcept C203014093 @default.
• W2073375483 hasConcept C2777138892 @default.
• W2073375483 hasConcept C2779134260 @default.
• W2073375483 hasConcept C2779280984 @default.
• W2073375483 hasConcept C2780132546 @default.
• W2073375483 hasConcept C71924100 @default.
• W2073375483 hasConcept C7573103 @default.
• W2073375483 hasConcept C90924648 @default.
• W2073375483 hasConceptScore W2073375483C126322002 @default.
• W2073375483 hasConceptScore W2073375483C17991360 @default.
• W2073375483 hasConceptScore W2073375483C203014093 @default.
• W2073375483 hasConceptScore W2073375483C2777138892 @default.
• W2073375483 hasConceptScore W2073375483C2779134260 @default.
• W2073375483 hasConceptScore W2073375483C2779280984 @default.
• W2073375483 hasConceptScore W2073375483C2780132546 @default.
• W2073375483 hasConceptScore W2073375483C71924100 @default.
• W2073375483 hasConceptScore W2073375483C7573103 @default.
• W2073375483 hasConceptScore W2073375483C90924648 @default.
• W2073375483 hasIssue "1" @default.
• W2073375483 hasLocation W20733754831 @default.
• W2073375483 hasLocation W20733754832 @default.
• W2073375483 hasLocation W20733754833 @default.
• W2073375483 hasOpenAccess W2073375483 @default.
• W2073375483 hasPrimaryLocation W20733754831 @default.
• W2073375483 hasRelatedWork W1588288904 @default.
• W2073375483 hasRelatedWork W1979155011 @default.
• W2073375483 hasRelatedWork W2052175477 @default.

• next